Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GB 004

Drug Profile

GB 004

Alternative Names: AKB-4924; GB-004

Latest Information Update: 15 Oct 2020

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Procter & Gamble
  • Developer Aerpio Pharmaceuticals; Gossamer Bio
  • Class Anti-inflammatories; Antiulcers; Piperazines; Pyridones; Small molecules
  • Mechanism of Action Hypoxia inducible factor 1 modulators; Prolyl hydroxylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Ulcerative colitis
  • No development reported Inflammatory bowel diseases

Most Recent Events

  • 13 Oct 2020 Efficacy data from a phase Ib trial in Ulcerative colitis released by Gossamer
  • 30 Sep 2020 Phase-II clinical trials in Ulcerative colitis (In the elderly, In adults) in USA (PO) (NCT04556383)
  • 11 Aug 2020 Gossamer Bio plans a phase II SHIFT-UC trial for Ulcerative colitis in the second half of 2020 (NCT04556383) (EudraCT2020-002306-12)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with a username/password associated to your organization’s account.
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Federated access using single sign-on credentials.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top